Objective:

To advance biomedical research beyond animal models and enhance human-based technologies for drug development and assessment.

Approach:

• Investment in Infrastructure: NIH is investing over $88 million in biomedical infrastructure projects across the U.S. to support New Approach Methodologies (NAMs).
• Quantum-Enabled Approaches Challenge: A challenge with over $7 million in awards aims to demonstrate how quantum technology can enhance detection and measurement in NAMs.
• Bio Genesis Laboratory: A new laboratory at the NIH Clinical Center will integrate human organoid models, robotics, AI, and advanced data capabilities for reproducible human biological experiments.
• Recruitment of Grant Reviewers: NIH will recruit reviewers with expertise in human-based science to evaluate emerging technologies.
• Request for Information: NIH is seeking input on the feasibility of annual reporting of vertebrate animals used in NIH-funded research.

Key Findings:

• NIH aims to reduce dependence on animal models in biomedical research.
• The initiatives support a broad geographic distribution of funding across nine states.
• The Qu-SAFE Challenge seeks to improve drug safety and toxicity assessment using quantum technology.

Interpretation:

NIH is establishing the scientific infrastructure required to develop, validate, and scale technologies that more accurately represent human biology.

Limitations:

• The initiatives may face challenges in transitioning from animal-based to human-based research methodologies.
• The effectiveness of new technologies in predicting human responses remains to be validated.

Conclusion:

NIH's initiatives focus on advancing human-centric research methodologies to improve the relevance and applicability of biomedical discoveries.

Sources:

• NIH Official Website